SERPINE2 haplotype as a risk factor for panlobular type of emphysema
Open Access
- 7 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genetics
- Vol. 12 (1), 157
- https://doi.org/10.1186/1471-2350-12-157
Abstract
Background: SERPINE2 (serpin peptidase inhibitor, clade E, member 2) has previously been identified as a positional candidate gene for chronic obstructive pulmonary disease (COPD) and has subsequently been associated to COPD and emphysema in several populations. We aimed to further examine the role of SERPINE2 polymorphisms in the development of pulmonary emphysema and different emphysema subtypes. Methods: Four single nucleotide polymorphisms (SNPs) in SERPINE2 were analyzed from 951 clinically and radiologically examined Finnish construction workers. The genotype and haplotype data was compared to different emphysematous signs confirmed with high-resolution computed tomography (HRCT), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), diffusing capacity (DLCO), and specific diffusing capacity (DLCO/VA). Results: Three of the studied SERPINE2 SNPs (rs729631, rs975278, and rs6748795) were found to be in tight linkage disequilibrium. Therefore, only one of these SNPs (rs729631) was included in the subsequent analyses, in addition to the rs840088 SNP which was in moderate linkage with the other three studied SNPs. The rs729631 SNP showed a significant association with panlobular emphysema (p = 0.003). In further analysis, the variant allele of the rs729631 SNP was found to pose over two-fold risk (OR 2.22, 95% CI 1.05-4.72) for overall panlobular changes and over four-fold risk (OR 4.37, 95% CI 1.61-11.86) for pathological panlobular changes. A haplotype consisting of variant alleles of both rs729631 and rs840088 SNPs was found to pose an almost four-fold risk for overall panlobular (OR 3.72, 95% CI 1.56-8.90) and subnormal (OR 3.98, 95% CI 1.55-10.20) emphysema. Conclusions: Our results support the previously found association between SERPINE2 polymorphisms and pulmonary emphysema. As a novel finding, our study suggests that the SERPINE2 gene may in particular be involved in the development of panlobular changes, i.e., the same type of changes that are involved in alpha-1-antitrypsin (AAT) -deficiency.Keywords
This publication has 31 references indexed in Scilit:
- Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy casesBMC Medical Genetics, 2010
- Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPDEuropean Respiratory Journal, 2010
- Absence of association between SERPINE2genetic polymorphisms and chronic obstructive pulmonary disease in Han Chinese: a case-control cohort studyBMC Medical Genetics, 2009
- Rate of progression of lung function impairment in 1-antitrypsin deficiencyEuropean Respiratory Journal, 2009
- SERPINE2 Polymorphisms and Chronic Obstructive Pulmonary DiseaseJournal of Korean Medical Science, 2009
- Chest CT screening of asbestos-exposed workers: lung lesions and incidental findingsEuropean Respiratory Journal, 2006
- The SERPINE2 Gene Is Associated with Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2006
- The SERPINE2 Gene and Chronic Obstructive Pulmonary DiseaseAmerican Journal of Human Genetics, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990